FDA announces comprehensive regenerative medicine policy framework

FDA announces comprehensive regenerative medicine policy framework

Today the U.S. Food and Drug Administration announced a comprehensive policy framework for the development and oversight of regenerative medicine products, including novel cellular therapies.

Read more here.


Leave a Reply

Your email address will not be published. Required fields are marked *


Home / Featured (sidebar) / FDA announces comprehensive regenerative medicine policy framework